Everyone needs to pay attention to this!
Denver Health paramedics, doctors, and nurses have just been vaccinated with a live Ebola vaccine,” said Dr. Richard Bartlett Friday on The Alex Jones Show. “Never before have we had anyone in Denver, Colorado – or Colorado at all – vaccinated for Ebola. This is history-making.”
“Why would they be doing this? They said they’re doing it in preparation for a ‘potential Ebola outbreak,’ why would they be thinking that’s possible?”
LINK
https://www.infowars.com/posts/cris...-up-136m-in-unpaid-care-in-2023-alone-report/
NATURALLY, I went searching for what could be helpful for us to fight this threat.
Abstract
The small molecule macrocyclic lactone ivermectin, approved by the US Food and Drug Administration for parasitic infections, has received renewed attention in the last eight years due to its apparent exciting potential as an antiviral. It was identified in a high-throughput chemical screen as inhibiting recognition of the nuclear localizing Human Immunodeficiency Virus-1 (HIV-1) integrase protein by the host heterodimeric importin (IMP) α/β1 complex, and has since been shown to bind directly to IMPα to induce conformational changes that prevent its normal function in mediating nuclear import of key viral and host proteins. Excitingly, cell culture experiments show robust antiviral action towards HIV-1, dengue virus (DENV), Zika virus, West Nile virus, Venezuelan equine encephalitis virus, Chikungunya virus, Pseudorabies virus, adenovirus, and SARS-CoV-2 (COVID-19). Phase III human clinical trials have been completed for DENV, with >50 trials currently in progress worldwide for SARS-CoV-2. This mini-review discusses the case for ivermectin as a host-directed broad-spectrum antiviral agent for a range of viruses, including SARS-CoV-2.
Keywords: ivermectin, antiviral, SARS-CoV-2, COVID-19, flavivirus, dengue virus, Zika virus”
Found here: Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?
“CRISIS: Denver Hospital Caught Injecting LIVE Ebola Vaccine In Workers Now Overwhelmed by Illegals…
Denver Health paramedics, doctors, and nurses have just been vaccinated with a live Ebola vaccine,” said Dr. Richard Bartlett Friday on The Alex Jones Show. “Never before have we had anyone in Denver, Colorado – or Colorado at all – vaccinated for Ebola. This is history-making.”
“Why would they be doing this? They said they’re doing it in preparation for a ‘potential Ebola outbreak,’ why would they be thinking that’s possible?”
LINK
https://www.infowars.com/posts/cris...-up-136m-in-unpaid-care-in-2023-alone-report/
NATURALLY, I went searching for what could be helpful for us to fight this threat.
Abstract
The small molecule macrocyclic lactone ivermectin, approved by the US Food and Drug Administration for parasitic infections, has received renewed attention in the last eight years due to its apparent exciting potential as an antiviral. It was identified in a high-throughput chemical screen as inhibiting recognition of the nuclear localizing Human Immunodeficiency Virus-1 (HIV-1) integrase protein by the host heterodimeric importin (IMP) α/β1 complex, and has since been shown to bind directly to IMPα to induce conformational changes that prevent its normal function in mediating nuclear import of key viral and host proteins. Excitingly, cell culture experiments show robust antiviral action towards HIV-1, dengue virus (DENV), Zika virus, West Nile virus, Venezuelan equine encephalitis virus, Chikungunya virus, Pseudorabies virus, adenovirus, and SARS-CoV-2 (COVID-19). Phase III human clinical trials have been completed for DENV, with >50 trials currently in progress worldwide for SARS-CoV-2. This mini-review discusses the case for ivermectin as a host-directed broad-spectrum antiviral agent for a range of viruses, including SARS-CoV-2.
Keywords: ivermectin, antiviral, SARS-CoV-2, COVID-19, flavivirus, dengue virus, Zika virus”
Found here: Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?
Last edited: